• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药使用相关的胃肠道损伤:一项病例研究及危险因素与预防策略综述

Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies.

作者信息

Goldstein Jay L, Cryer Byron

机构信息

Department of Medicine, NorthShore University HealthSystem, Evanston, IL, USA.

Division of Gastroenterology, University of Texas Southwestern Medical Center and Dallas VA Medical Center, Dallas, TX, USA.

出版信息

Drug Healthc Patient Saf. 2015 Jan 22;7:31-41. doi: 10.2147/DHPS.S71976. eCollection 2015.

DOI:10.2147/DHPS.S71976
PMID:25653559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4310346/
Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and analgesic agents and are among the most commonly used classes of medications worldwide. However, their use has been associated with potentially serious dose-dependent gastrointestinal (GI) complications such as upper GI bleeding. GI complications resulting from NSAID use are among the most common drug side effects in the United States, due to the widespread use of NSAIDs. The risk of upper GI complications can occur even with short-term NSAID use, and the rate of events is linear over time with continued use. Although gastroprotective therapies are available, they are underused, and patient and physician awareness and recognition of some of the factors influencing the development of NSAID-related upper GI complications are limited. Herein, we present a case report of a patient experiencing a gastric ulcer following NSAID use and examine some of the risk factors and potential strategies for prevention of upper GI mucosal injuries and associated bleeding following NSAID use. These risk factors include advanced age, previous history of GI injury, and concurrent use of medications such as anticoagulants, aspirin, corticosteroids, and selective serotonin reuptake inhibitors. Strategies for prevention of GI injuries include anti-secretory agents, gastroprotective agents, alternative NSAID formulations, and nonpharmacologic therapies. Greater awareness of the risk factors and potential therapies for GI complications resulting from NSAID use could help improve outcomes for patients requiring NSAID treatment.

摘要

非甾体抗炎药(NSAIDs)是有效的抗炎和镇痛药,也是全球最常用的药物类别之一。然而,其使用与潜在的严重剂量依赖性胃肠道(GI)并发症相关,如上消化道出血。由于NSAIDs的广泛使用,NSAIDs使用导致的GI并发症是美国最常见的药物副作用之一。即使短期使用NSAIDs也可能发生上消化道并发症的风险,并且随着持续使用,事件发生率随时间呈线性增加。尽管有胃保护疗法,但它们未得到充分利用,并且患者和医生对一些影响NSAID相关上消化道并发症发生的因素的认识和识别有限。在此,我们报告一例使用NSAIDs后发生胃溃疡的患者病例,并探讨一些危险因素以及预防NSAIDs使用后上消化道黏膜损伤和相关出血的潜在策略。这些危险因素包括高龄、既往GI损伤史以及同时使用抗凝剂(如阿司匹林、皮质类固醇和选择性5-羟色胺再摄取抑制剂)等药物。预防GI损伤的策略包括抗分泌剂、胃保护剂、替代NSAID制剂和非药物疗法。提高对NSAIDs使用导致的GI并发症的危险因素和潜在疗法的认识,可能有助于改善需要NSAID治疗的患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a099/4310346/772616f6f560/dhps-7-031Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a099/4310346/c83c43df6a60/dhps-7-031Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a099/4310346/772616f6f560/dhps-7-031Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a099/4310346/c83c43df6a60/dhps-7-031Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a099/4310346/772616f6f560/dhps-7-031Fig2.jpg

相似文献

1
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies.非甾体抗炎药使用相关的胃肠道损伤:一项病例研究及危险因素与预防策略综述
Drug Healthc Patient Saf. 2015 Jan 22;7:31-41. doi: 10.2147/DHPS.S71976. eCollection 2015.
2
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].[非甾体抗炎药所致胃肠道溃疡及其并发症的防治建议]
Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021.
3
Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.优化 NSAIDs 治疗方案以降低胃肠道和心血管不良事件风险的策略。
Clin Ther. 2010 Apr;32(4):667-77. doi: 10.1016/j.clinthera.2010.04.009.
4
Challenges in managing NSAID-associated gastrointestinal tract injury.非甾体抗炎药相关性胃肠道损伤的管理挑战。
Digestion. 2004;69 Suppl 1:25-33. doi: 10.1159/000076554.
5
Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly.老年长期使用者中对非甾体抗炎药引起的胃肠道事件的不恰当预防。
Drugs Aging. 2007;24(2):121-31. doi: 10.2165/00002512-200724020-00004.
6
Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.老年非甾体抗炎药/COX-2 选择性抑制剂使用者同时使用胃保护药物的情况:一项基于全国登记处的研究。
Clin Drug Investig. 2008;28(11):687-95. doi: 10.2165/00044011-200828110-00002.
7
Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?质子泵抑制剂与非甾体抗炎药联合治疗——有益还是必要?
Rev Gastroenterol Disord. 2004;4 Suppl 4:S33-41.
8
GI risk and risk factors of NSAIDs.非甾体抗炎药的胃肠道风险及危险因素。
J Cardiovasc Pharmacol. 2006;47 Suppl 1:S60-6. doi: 10.1097/00005344-200605001-00011.
9
Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NSAIDs, and Gastroprotective Cotherapy: An Appraisal of the Literature.环氧化酶(COX)-1/COX-2非甾体抗炎药(NSAIDs)、COX-2选择性NSAIDs及胃保护联合治疗患者的上消化道损伤风险与事件:文献评估
J Clin Rheumatol. 2004 Aug;10(4):178-89. doi: 10.1097/01.rhu.0000128851.12010.46.
10
NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.非甾体抗炎药相关不良反应及预防这些不良反应的抑酸辅助药物:当前治疗选择综述
Drug Saf. 2006;29(2):119-32. doi: 10.2165/00002018-200629020-00002.

引用本文的文献

1
Gastroprotective, Antioxidant, Anti-Inflammatory, and Toxicological Evaluation of Stem Bark Extracts of and .[植物名称1]和[植物名称2]茎皮提取物的胃保护、抗氧化、抗炎及毒理学评价
Pharmaceuticals (Basel). 2025 Aug 11;18(8):1184. doi: 10.3390/ph18081184.
2
Self-Medication with NSAIDs in Gondar city: prevalence, predictors, and public health implications.贡德尔市非甾体抗炎药的自我药疗:患病率、预测因素及对公共卫生的影响
Sci Rep. 2025 Jul 7;15(1):24178. doi: 10.1038/s41598-025-10183-y.
3
Surge Dose Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling.

本文引用的文献

1
Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications.非甾体抗炎药的不良反应:胃肠道、心血管和肾脏并发症的最新进展。
J Pharm Pharm Sci. 2013;16(5):821-47. doi: 10.18433/j3vw2f.
2
Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial.在CONDOR试验中,塞来昔布以及双氯芬酸加奥美拉唑在治疗高胃肠道风险患者的关节炎方面疗效相似。
Open Rheumatol J. 2013 Nov 13;7:96-100. doi: 10.2174/1874312901307010096. eCollection 2013.
3
The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage.
非甾体抗炎药的冲击剂量制剂在空腹和进食状态下均能实现超快速且一致的药物吸收,这是基于生理的生物药剂学模型所预测的。
Pharmaceutics. 2025 May 28;17(6):708. doi: 10.3390/pharmaceutics17060708.
4
Intestinal barrier damage caused by addictive substance use disorder.成瘾物质使用障碍导致的肠道屏障损伤
Eur J Med Res. 2025 Apr 2;30(1):226. doi: 10.1186/s40001-025-02446-1.
5
Research hotspots and frontiers in non-specific low back pain: a bibliometric analysis.非特异性下腰痛的研究热点与前沿:一项文献计量学分析
Front Neurol. 2024 Oct 30;15:1464048. doi: 10.3389/fneur.2024.1464048. eCollection 2024.
6
Study on the Consumption of Non-Steroidal Anti-Inflammatory Drugs and Antibiotics by the Brazilian Adult Population: A Cohort Study.巴西成年人群非甾体抗炎药和抗生素消费情况研究:一项队列研究
Pharmacy (Basel). 2024 Sep 29;12(5):150. doi: 10.3390/pharmacy12050150.
7
based Designing of benzothiazol-2-amine Derivatives as Analgesic and Anti-inflammatory Agents.基于苯并噻唑-2-胺衍生物的设计,作为镇痛和抗炎药物。
Antiinflamm Antiallergy Agents Med Chem. 2024;23(4):230-260. doi: 10.2174/0118715230296273240725065839.
8
Management of potentially inappropriate medication use among older adult's patients in primary care settings: description of an interventional prospective non-randomized study.基层医疗中老年患者潜在不适当药物使用的管理:一项干预性前瞻性非随机研究的描述。
BMC Prim Care. 2024 Jun 13;25(1):213. doi: 10.1186/s12875-024-02334-3.
9
Self-reported gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs in female students with dysmenorrhoea at Makerere University: prevalence, discontinuation and associated factors. a cross sectional study.在 Makerere 大学,痛经女学生自述的非甾体抗炎药胃肠道不良反应:患病率、停药率及相关因素。一项横断面研究。
BMJ Open. 2024 Jun 6;14(6):e079660. doi: 10.1136/bmjopen-2023-079660.
10
Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage.透明质酸-布洛芬共轭物:一种保护内耳细胞免受炎症介导损伤的新型耳治疗方法。
Front Pharmacol. 2024 Feb 15;15:1355283. doi: 10.3389/fphar.2024.1355283. eCollection 2024.
质子泵抑制剂在治疗和预防 NSAID 诱导的黏膜损伤中的应用。
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S5. doi: 10.1186/ar4177. Epub 2013 Jul 24.
4
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.非甾体抗炎药与上、下胃肠道黏膜损伤。
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S3. doi: 10.1186/ar4175. Epub 2013 Jul 24.
5
Indomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 study.吲哚美辛亚微颗粒胶囊为急性疼痛患者提供有效止痛:一项 3 期研究。
Phys Sportsmed. 2013 Nov;41(4):7-15. doi: 10.3810/psm.2013.11.2031.
6
A phase 2 study of naproxen submicron particle capsules in patients with post-surgical dental pain.一项关于萘普生亚微米颗粒胶囊治疗术后牙科疼痛患者的 2 期研究。
Adv Ther. 2013 Oct;30(10):885-96. doi: 10.1007/s12325-013-0057-9. Epub 2013 Oct 15.
7
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.在一项 3 期研究中,低剂量双氯芬酸亚微颗粒胶囊为急性疼痛患者提供了早期和持续的缓解。
Postgrad Med. 2013 Sep;125(5):130-8. doi: 10.3810/pgm.2013.09.2693.
8
Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.非甾体抗炎药对胃肠道癌症的影响:当前科学现状。
Cancer Lett. 2014 Apr 10;345(2):249-57. doi: 10.1016/j.canlet.2013.09.001. Epub 2013 Sep 7.
9
Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives.非甾体抗炎药反应的变异性:机制与展望。
Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):56-63. doi: 10.1111/bcpt.12117. Epub 2013 Sep 3.
10
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population.美国普通人群中阿司匹林和非甾体抗炎药的使用趋势。
Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):43-50. doi: 10.1002/pds.3463. Epub 2013 May 30.